Related Experiment Video

Updated: Jul 3, 2026

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis
07:14

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis

Published on: October 19, 2021

Helena Kagan (1889-1978): the first paediatrician in Israel

Zipora Rubin1

  • 1Kaye Academic College of Education, Beer-Sheva, Israel. zipirubin@walla.com

Journal of Medical Biography
|July 26, 2008
PubMed

Insights

Dr. Helena Kagan pioneered pediatric care in Jerusalem in 1914, establishing the nation's first pediatric clinic from her home. Her work significantly improved child health and community well-being through dedicated public health initiatives.

Area of Science:

  • Medical History
  • Public Health
  • Pediatrics

Background:

  • Helena Kagan, a 25-year-old physician, established her practice in Jerusalem in 1914.
  • She became the first pediatrician in the region, opening a clinic in her home.

Discussion:

  • Kagan's initiative addressed a critical need for specialized child healthcare in early 20th-century Jerusalem.
  • Her work laid the foundation for future pediatric services and public health infrastructure.

Key Insights:

  • Pioneering pediatric practice in a developing region.
  • Establishing healthcare institutions to serve vulnerable populations.
  • The impact of a single physician's dedication on community health.

Outlook:

  • The legacy of Kagan's work continues to influence pediatric care and public health strategies.
  • Further research could explore the long-term impact of her founded institutions.
  • Understanding historical public health pioneers offers valuable lessons for contemporary challenges.

More Related Videos

Isolation of Neonatal Extrahepatic Cholangiocytes07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...